About IGM

IGM Leadership
Pictured left to right is The Steve and Cindy Rasmussen Institute for Genomic Medicine leadership: Peter White, PhD, senior director, Computational Genomics Group; Rick Wilson, PhD, executive director; Elaine Mardis, PhD, co-executive director; Vince Magrini, PhD, director, Technology Development; Julie Gastier-Foster, PhD, ACMG, senior director Clinical Laboratory; and Catherine Cottrell, PhD, FACMG, senior director and director, Clinical Next Generation Sequencing.

This vision reached a tipping point in 2016 with the recruitment of preeminent scientists Elaine Mardis, PhD, and Richard Wilson, PhD from Washington University-St. Louis and the expertise of Nationwide Children's faculty, including Julie Gastier-Foster, PhD, and Peter White, PhD.

The Institute’s Strategic Plan

Our Strategic Plan envisions the integration of our capabilities throughout Nationwide Children’s Hospital. Expanding the availability of clinical genetic and genomic testing will enable providers to diagnose conditions earlier, better predict patient outcomes and personalize treatment to each individual patient.

Institute for Genomic Medicine

The Institute at a Glance

Institute for Genomic Medicine

“It is much easier to know your enemy. Genomics allows us to know our enemy better.”

- Tim Cripe, chief
Hematology, Oncology and Blood and Marrow Transplant

“We are not taking traditional approaches to medication choices. Instead of a shotgun or blind approach we are making targeted decisions based on genomic results.”

- Anup Patel, chief